<DOC>
	<DOCNO>NCT01758380</DOCNO>
	<brief_summary>To evaluate vildagliptin compare gliclazide , give combination metformin Muslim patient type 2 diabetes fast Ramadan .</brief_summary>
	<brief_title>Vildagliptin Compared Gliclazide Dual Therapy With Metformin Muslim Patients With Type 2 Diabetes Fasting During Ramadan</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>Confirmed Type 2 Diabetes diagnosis Plan fast Ramadan Treated combination metformin Sulfonylurea ( SU ) least 12 week HbA1c ≤8.5 % Visit 1 Taking sulfonylurea treatment le 3 year prior Visit 1 Body mass index ( BMI ) ≥22 ≤45 kg/m2 Visit 1 Pregnant nursing ( lactate ) woman History hypersensitivity study drug drug similar chemical class . Patients take antidiabetes drug ( oral injection ) metformin SU component . Inability comply study procedure medication . `` Other protocoldefined inclusion/exclusion criterion may apply ''</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Ramadan</keyword>
	<keyword>Vildagliptin</keyword>
	<keyword>Hypoglycemia</keyword>
</DOC>